Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.3601
-0.0009 (-0.25%)
At close: Aug 10, 2026
Elite Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, Elite Pharmaceuticals had annual revenue of $148.87M with 77.13% growth. Elite Pharmaceuticals had revenue of $40.75M in the quarter ending March 31, 2026, with 27.35% growth.
Revenue
148.87M
Revenue Growth
+77.13%
P/S Ratio
2.61
Revenue / Employee
2.29M
Employees
65
Market Cap
387.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 148.87M | 64.83M | 77.13% |
| Mar 31, 2025 | 84.04M | 27.42M | 48.42% |
| Mar 31, 2024 | 56.63M | 22.47M | 65.79% |
| Mar 31, 2023 | 34.16M | 1.89M | 5.87% |
| Mar 31, 2022 | 32.26M | 6.88M | 27.11% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MariMed | 161.40M |
| Earth Science Tech | 35.96M |
| Radnostix | 12.21M |
| Healthy Extracts | 5.19M |
| Bio Essence | 2.38M |
| Growth Stalk Holdings | 583.34K |
Elite Pharmaceuticals News
- 6 days ago - Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL - Newsfile Corp
- 5 weeks ago - Elite Pharmaceuticals Earnings Call Transcript: Q4 2026 - Transcripts
- 5 weeks ago - Elite Pharmaceuticals Annual report: Q4 2026 - Filings
- 5 weeks ago - Elite Pharmaceuticals Earnings release: Q4 2026 - Filings
- 6 weeks ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information - Newsfile Corp
- 6 weeks ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026 - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product - Newsfile Corp